Title: Clinical medication treatment analysis of chronic pneumocardial disease combined with cardiac failure
Abstract: Objective To investigate the clinical medication treatment of chronic pulmonary heart disease with heart failure.Methods Ninety cases of chronic pulmonary heart disease with heart failure were selected,which were randomly divided into observation group and control group,patients in control group were given conventional treatment such as anti-infection,diminish inflammation,oxygen,diuresis and correct electrolyte disorder,patients in observation group were given oral benazepril based on the treatment of control group.After 2 courses of treatment,the cardiac function change condition and adverse reaction conditions were observed.Results The total effective rate of observation group (93.33%) was much higher than that of the control group(66.67%),and improvement of heart function was obviously superior to the control group,the pH and PaO2 rising degree and PaCO2 decreasing degree of observation group was significantly greater than those in control group,the differences between the two groups were significant (P < 0.05).In the observation group,6 cases had adverse reactions,while no adverse reaction occurred in control group.Conclusions Benazepril on the basis of conventional treatment in the treatment of chronic pulmonary heart disease combined with heart failure can effectively improve cardiac function of patients,and has less adverse reactions,all patients can tolerate.
Key words:
Chronic pulmonary heart disease; Heart failure; Benazepril
Publication Year: 2013
Publication Date: 2013-07-10
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot